You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 1, January 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE FOURTH ANNUAL MEETING OF THE SURGICAL INFECTION SOCIETY, MONTREAL, APRIL 30 to MAY 1, 1984-PART 1
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (18)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Mechanisms of Action of Two New Immunomodulators

J. Paul Waymack, MD; Sara Gonce; Phillip Miskell; J. Wesley Alexander, MD, ScD

Arch Surg. 1985;120(1):43-48.


Abstract

• Despite antibiotics, infection remains a significant problem in surgical patients. The reasons are multiple, and include acquired immunologic deficiencies that are seen in malnutrition, sepsis, trauma, and burns. Two immunomodulators, thymopentin (TP-5) and CP-46,665, have been shown to improve survival in infectious animal models of such deficiencies. We investigated the mechanism of action in guinea pigs subjected to a burn of 30% of the total body surface area. These animals received 0.3 mg/kg of thymopentin, 0.3 mg/kg of CP-46,665, or saline solution. Neutrophils, macrophages, and serum samples were obtained from the animals and tested for their ability to phagocytose and kill Pseudomonas aeruginosa. The serum was tested for its ability to opsonize Escherichia coli. Thymopentin was found to improve neutrophil function on postburn days 2 and 4 and to improve macrophage function on postburn day 4. CP-46,665 was found to improve both macrophage function and opsonization on postburn day 2.

(Arch Surg 1985;120:43-48)



Author Affiliations

From the Department of Research, Shriners Burns Institute, Cincinnati (Drs Waymack and Alexander and Mr Miskell); and the Department of Surgery, University of Cincinnati Medical Center (Drs Waymack and Alexander and Ms Gonce).


Footnotes

Accepted for publication Aug 27, 1984.

Read before the Fourth Annual Meeting of the Surgical Infection Society, Montreal, May 1, 1984.

Reprint requests to Shriners Burns Institute, 202 Goodman St, Cincinnati, OH 45219 (Dr Waymack).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Immune-Enhancing Effect of Perioperative Thymopentin Administration in Elderly Patients Undergoing Major Surgery
Faist et al.
Arch Surg 1988;123:1449-1453.
ABSTRACT  

Effect of Prostaglandin E on Immune Function in Multiple Animal Models
Waymack and Yurt
Arch Surg 1988;123:1429-1432.
ABSTRACT  

Burn Wound Sepsis
Hansbrough
J Intensive Care Med 1987;2:313-327.
ABSTRACT  

Effects of Fish Oil on Postburn Metabolism and Immunity
Trocki et al.
JPEN J Parenter Enteral Nutr 1987;11:521-528.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.